Skip to main content
NCBI home page
Zoological Research logoLink to Zoological Research
. 2018 Feb 9;39(1):42–51. doi: 10.24272/j.issn.2095-8137.2018.015

Parasites may exit immunocompromised northern pig-tailed macaques (Macaca leonina) infected with SIVmac239

Tian-Zhang Song 1,2,#, Ming-Xu Zhang 1,#, Yu-Jie Xia 3, Yu Xiao 1, Wei Pang 1, Yong-Tang Zheng 1,3,*
PMCID: PMC5869241  PMID: 29511144

Abstract

Parasites can increase infection rates and pathogenicity in immunocompromised human immunodeficiency virus (HIV) patients. However, in vitro studies and epidemiological investigations also suggest that parasites might escape immunocompromised hosts during HIV infection. Due to the lack of direct evidence from animal experiments, the effects of parasitic infections on immunocompromised hosts remain unclear. Here, we detected 14 different parasites in six northern pig-tailed macaques (NPMs) before or at the 50th week of simian immunodeficiency virus (SIV) infection by ELISA. The NPMs all carried parasites before viral injection. At the 50th week after viral injection, the individuals with negative results in parasitic detection (i.e., 08247 and 08287) were characterized as the Parasites Exit (PE) group, with the other individuals (i.e., 09203, 09211, 10205, and 10225) characterized as the Parasites Remain (PR) group. Compared with the PR group, the NPMs in the PE group showed higher viral loads, lower CD4+ T cells counts, and lower CD4/CD8 rates. Additionally, the PE group had higher immune activation and immune exhaustion of both CD4+ and CD8+ T cells. Pathological observation showed greater injury to the liver, cecum, colon, spleen, and mesenteric lymph nodes in the PE group. This study showed more seriously compromised immunity in the PE group, strongly indicating that parasites might exit an immunocompromised host.

Keywords: AIDS, Immunocompromised, Northern pig-tailed macaque, Parasite, SIVmac239

INTRODUCTION

Acquired Immune Deficiency Syndrome (AIDS), induced by human immunodeficiency virus (HIV), was first recognized in 1981 and has emerged from initially being a concern among high-risk groups to representing a worldwide pandemic (Jeang et al., 2007). According to estimates by WHO and UNAIDS, 36.7 million people were living with HIV globally at the end of 2015. That same year, approximately 2.1 million people became newly infected and 1.1 million died of HIV-related causes. As HIV specifically acts on the immune system, destroying or impairing its function, the most common causes of death for HIV patients are various pathogenic infections (including fungal, viral, bacterial, and parasitic infections) and cancer (Bonnet et al., 2005; Antiretroviral Therapy Cohort Collaboration, 2010; Palladino et al., 2011).

Both parasites and HIV infection have major effects on the host immune system, and co-infection is widespread (Bentwich, 2000). Helminths can induce a Th2 bias, leading to suppression of Th1 responses to HIV, as well as to expansion of Th2 lymphocytes that are more susceptible to HIV infection (Bentwich et al., 1999). Several epidemiological and systematic studies claim that deworming is a preventive and possibly therapeutic measure in patients co-infected with helminths and HIV (Borkow & Bentwich, 2006; Walson et al., 2009; Walson & John-Stewart, 2007), thus indicating the potential side effect of parasites. However, a more recent meta-analysis showed that deworming has little or no favorable effect on HIV treatment (Means et al., 2016). Unfortunately, direct experimental evidence from animal models is still missing, and the relationship between parasites and HIV remains complex and unclear.

Non-human primates (NHPs) are crucial animal models for understanding the pathogenesis of HIV infection (Karlsson et al., 1997; Letvin, 1992). Simian immunodeficiency virus (SIV) infections in rhesus macaques and northern pig-tailed macaques (NPMs) result in an immunocompromised and AIDS-like disease similar to that seen in HIV patients, as established in our laboratory (Pang et al., 2017; Zhang et al., 2017a, b). In this study, NPMs with different parasitic loads after infection with SIVmac239 were used to detect immunological and pathological differences to reveal the relationship between viral infection and parasites.

MATERIALS AND METHODS

Ethics statement

All animal experiments were performed according to the guidelines of the Committee on Animals of the Kunming Institute of Zoology, Chinese Academy of Sciences (approval number: SYDW-2015023). NPMs included in this study were housed at the Kunming Primate Research Center under the guidance of the American Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC).

Animals and sample collection

After evaluating each individual for B virus, SIV, STLV, and SRV by PCR, six negative male NPMs (5–7 years old, numbered 08247, 08287, 09203, 09211, 10205, and 10225) were enrolled in this study. Each NPM was inoculated with 2 mL of normal saline containing a 3 000 50% tissue culture infection dose (TCID50) of SIVmac239 into the posterior tibial vein. Peripheral blood was collected into an EDTAK2 vacutainer by venipuncture. Subsequently, peripheral blood mononuclear cells (PBMCs) were separated by Ficoll density gradient centrifugation (2 500 r/min, 20 min). PBMCs and plasma were stored in liquid nitrogen and frozen at −80 °C, respectively. Ketamine hydrochloride (0.2 mL/kg) was used to anaesthetize animals prior to experiments.

Parasite detection

Pre-infection and at the 50th week after viral infection, plasma from the NPMs was collected and evaluated for parasitic status. In total, 14 types of parasites were included in this study. Entamoeba histolytica was detected by thick smear, as described previously (Warhurst & Williams, 1996). Trypanosoma brucei, Cryptosporidium parvum, Plasmodium knowlesi, Toxoplasma gondii, Giardia lamblia, Echinococcus granulosus, Clonorchis sinensis, Schistosoma japonicum, Paragonimus spp., filarial worms, and Trichinella spiralis were detected by their respective parasitic antigen ELISA kits (MEIMIAN, China) following the manufacturer’s instructions. Spirometra mansoni and Angiostrongylus cantonensis were detected by their respective human antibodies ELISA kits (MEIMIAN, China; JIANLUN, China) following the manufacturer’s instructions. For all ELISA experiments, the Calculate Critical (CUT OFF) value was equal to the average of the negative control well plus 0.15. The well with an OD greater than or equal to the CUT OFF was regarded as a positive result.

Full blood differential counts

Before separation of PBMCs, 80 µL of blood was removed from the EDTAK2 vacutainer. Whole blood differential counts were performed by an auto hematology analyzer (RR-OB101338, MINDRAY, Shenzhen, China) according to the manufacturer’s instructions.

Plasma viral loads

Viral loads in plasma were measured by quantitative PCR for SIV gag RNA, as described previously (Tian et al., 2015) (SIV F: 5'-TCGGTCTTAGCTCCATTAGTGCC-3'; SIV R: 5'-GCTTCCTCAGTGTGTTTCACTTTC-3'; SIV probe: 5'-CTTCTGCGTGAATGCACCAGATGACGC-3').

Flow cytometry

Multicolor flow cytometric analysis was performed as described previously (Xia et al., 2009; Zheng et al., 2014). Anti-CD3 PE (clone SP34-2), anti-CD8 PECy7 (clone RPA-T8), anti-CD20 FITC (clone 2H7), anti-CD14 APC (clone M5E2), anti-CD3 APC-Cy7 (clone SP34-2), and anti-HLA-DR APC (clone G46-6) were purchased from BD Pharmingen (Franklin Lakes, New Jersey, USA). Anti-CD4 PerCP (clone OKT4) was purchased from Biolegend (San Diego, CA, USA). Anti-CD38 FITC (clone AT-1) was purchased from STEMCELL (Vancouver, Canada). Anti-PD-1 PE (clone eBioJ105) was purchased from eBioscience (San Diego, CA, USA). Samples were processed on a BD FACSVerse flow cytometer (Franklin Lakes, New Jersey, USA), and data were analysed using FlowJo software (vX.0.7, Tree Star).

Tissue collection and histopathology

Both 08247 and 09211 died naturally on the 70th and 68th weeks after viral infection, respectively. Tissues were fixed in 10% formaldehyde and later embedded in paraffin. The paraffin-embedded samples were cut into 4-μm-thick sections and stained with hematoxylin-eosin (H&E). All samples were photographed and examined using a LEICA DMI 4000B microscope (Germany).

Statistical analysis

For all data, GraphPad 6.0 was used to perform statistical analyses. Two-way analysis of variance (ANOVA) was used to compare all data. P<0.05 were regarded as statistically significant.

RESULTS

Parasitic infection status and categories

The parasitic infection statuses of the NPMs are shown in Table 1. None of the NPMs was infected with Plasmodium knowlesi, Echinococcus granulosus, Clonorchis sinensis, Paragonimus spp., Angiostrongylus cantonensis, Trichinella spiralis, or Spirometra mansoni. Both 08247 and 08287 showed positive parasitic reactions before viral infection, and negative reactions after infection. However, 09203, 09211, 10205, and 10225 exhibited substantially different results. At the 50th week after infection, the parasites detected before viral infection remained, and no new parasites were detected after viral infection. Therefore, we grouped 08247 and 08287 into the Parasites Exit (PE) group and the other four NPMs into the Parasites Remain (PR) group to evaluate the relationship between SIV and parasitic infection.

Table 1.

Parasitic infection status

No. SIV Infection (N/Y) Protozoa
Trypanosoma brucei Cryptosporidium parvum Plasmodium knowlesi Entamoeba histolytica Toxoplasma gondii Giardia lamblia
08247 N + + - - + +
Y - - - - - -
08287 N + + - - + +
Y - - - - - -
09203 N + + - - - -
Y + + - - + -
09211 N + - - - - -
Y + - - - - -
10205 N + + - - - -
Y + + - - - -
10225 N + + - + + -
Y + + - + + +
Open in a new tab

Higher viral loads in the PE group

NPMs in both groups had peak plasma viral loads at the second to third week post-infection, after which the viral loads showed a downward trend until the sixth week after injection (Figure 1). Afterwards, the PE and PR groups showed substantially different trends. Viral loads in the PE group stopped decreasing and generally stabilized at 104–105 copies/mL. However, the PR group showed a continuing downward trend, and approached detection limits at the 40th–50th weeks after infection. In this study, the 50 experimental weeks were divided into SIV acute phase and SIV chronic phase at the 12th week post infection to perform additional analysis (Pantaleo et al., 1993b). Compared with the PR group, the PE group showed significantly higher plasma viral loads in the chronic stage (P<0.000 1).

Figure 1.

Figure 1

Open in a new tab

Plasma viral loads in the PE and PR groups

Lower CD4+ T cell levels in the PE group

Absolute counts of CD4+ T cells, the primary cells infected by HIV or SIV, were evaluated by flow cytometry. Compared with the PR group, NPMs in the PE group had significantly fewer CD4+ T cells in peripheral blood (P<0.000 1, Figure 2A). This was in accordance with the results in Figure 2B, which show a significantly lower CD4+/CD8+ T cell rate in the PE group (P<0.001). These two results strongly indicated that the NPMs in the PE group had more seriously damaged CD4+ T cells.

Figure 2.

Dynamics of CD4+ T cells in peripheral blood

Figure 2

A: Absolute counts of CD4+ T cells; B: Ratio between CD4+ T cells and CD8+ T cells.

Open in a new tab

Immune activation and exhaustion

Chronic immune activation is proposed to be a key determinant of AIDS pathogenesis (Rajasuriar et al., 2013), and was marked by CD38 and HLA-DR in this study. There were significant differences between the PE and PR groups in CD38 expression during the whole study period and in HLA-DR expression during the chronic phase in CD4+ and CD8+ T cells (Figure 3A, B, D, E). These data strongly indicated that NPMs in the PE group showed more obvious immune activation than those in the PR group during SIV infection. Additionally, the PE group had a higher level of PD-1 expression in CD4+ T cells during the whole study period (P<0.000 1) and in CD8+ T cells during the chronic phase (P=0.027 3), as shown in Figure 3C and 3F respectively. Collectively, these results revealed that NPMs in the PE group showed higher immune activation and more serious exhaustion of CD4+ and CD8+ T cells.

Figure 3.

Expression of immune activation and exhaustion markers

Figure 3

A, D: Expression of CD38 in CD4+ and CD8+ T cells; B, E: Expression of HLA-DR in CD4+ and CD8+ T cells; C, F: Expression of PD-1 in CD4+ and CD8+ T cells.

Open in a new tab

Cell distribution in peripheral blood

The fluctuant cell distribution in peripheral blood was shown in Figure 4. The number of white blood cells showed no significant differences between the two groups (Figure 4C). However, in the SIV acute and chronic phases, NPMs in the PE group showed fewer red blood cells compared with the PR group, as shown in Figure 4A. The number of platelets also significantly declined in the PE group compared with the PR group during the SIV chronic phase (Figure 4B), which is important given that platelet count is a main marker for immunocompromised thrombocytopenic purpura induced by HIV or SIV (O’Bryan et al., 2015).

Figure 4.

Cell distribution in peripheral blood

Figure 4

A: Red blood cell (RBC) counts; B: Platelet (PLT) counts; C: White blood cell (WBC) counts.

Open in a new tab

Dynamics of monocytes, B cells, and T cells in peripheral blood

Cell counts before viral infection were calculated as 100%. The dynamics of the three cell types were evaluated, as shown in Figure 5. Monocytes, which play an important role in innate immunity, showed a significant increase in the PE group compared with the PR group (Figure 5A). Conversely, T cells and B cells, markers of acquired immunity, were significantly reduced in the PE group compared with the PR group, as shown in Figure 5B, C.

Figure 5.

Figure 5

Open in a new tab

Dynamics of monocytes, B cells, and T cells in peripheral blood

Pathological observation of injured organs

In total, 22 organs from each NPM were collected and stained by H&E, four of which displayed obvious damage, as shown in Figure 6. Compared to PR-09211, which maintained almost normal hepatic lobule appearance, liver damage in PE-08247 was obvious (Figure 6A). Alimentary canal damage is strongly related to chronic immune activation (Griffin, 1990; Mestecky et al., 2009), and was detected in our study. In Figure 6C, D, obvious damage in the ileum of both 08247 and 09211 could be seen. Compared to 09211, PE-08247 demonstrated more serious injuries in the cecum without any observed enteraden and in the colon with a discrete and defective mucosal surface.

Figure 6.

Histological changes in liver, ileum, cecum, and colon

Figure 6

A, B: Liver (×200); C, D: Ileum (×100); E, F: Cecum (×100); G, H: Colon (×100). Red arrow: Fibrosis; Blue arrow: Hemorrhage; Yellow arrow: Hepatic lobule; Black arrow: Enteraden; White arrow: Connective tissue exposure; Red rectangle: Mucosal surface.

Open in a new tab

Pathological observation of immune organs

The spleen has no direct connection to the lymphatic system; instead, it collects antigens from the blood and is involved in immune responses to blood-borne pathogens (Murphy & Weaver, 2016). Compared to 09211, the white pulp of 08247 in the PE group had severe fibrosis and decreased lymphocytes, as shown in Figure 7A. Lymph nodes are the most important organ in HIV or SIV infection, spread, and damage to lymphocytes (Pantaleo et al., 1993a). As shown in Figure 7C–F, lymphoid follicles could be observed in all images, and there were no significant differences between the PE and PR groups in axillary and inguinal lymph nodes. However, compared to 09211 in the PR group, mesenteric lymph nodes in 08247 in the PE group were observed with lymphoid follicle fibrosis and decreased lymphocytes in the paracortex, strongly indicating more serious damage in the PE group (Figure 7G).

Figure 7.

Histological changes in immune organs (×100)

Figure 7

A, B: Spleen; C, D: Axillary lymph nodes; E, F: Inguinal lymph nodes; G, H: Mesenteric lymph nodes. Red arrow: Abnormal white pulp; Yellow arrow: White pulp; Black arrow: Lymphoid follicle; White arrow: Abnormal lymphoid follicle.

Open in a new tab

DISCUSSION

In this study, no parasites were detected in 08247 and 08287 in the PE group at the 50th week after viral infection, although both were positive for parasites before viral injection. In addition, in the PE group, more significant damage to the mucosal barrier, mesenteric lymph nodes, and immune cells were observed.

CD4+ T cell counts and viral loads are the most important indices used to predict disease progress and immune system damage (Rowley, 2014). The persistent decrease in CD4+ T cell counts with viral load increase represents serious immunological compromise and poor prognosis, which was observed in the PE group. In addition, immune activation is a sensitive index for predicting disease progression and is central to the understanding of HIV-1 disease pathogenesis and progression in association with inflammation (Ipp et al., 2014). Therefore, CD38 and HLA-DR, two markers of immune activation, were detected by flow cytometry in this study, which indicated more significant immune activation in the PE group compared with the PR group.

The loss of enteric mucosal barrier integrity is associated with rapid depletion of enteric lymphocytes, immune activation, and microbial translocation (Brenchley et al., 2006; Douek, 2007). As shown in Figure 6, PE-08247 exhibited serious damage to the mucosal barrier. Unsurprisingly, antigen origin from the translocation of microbes and other bacterial products stimulates mesenteric lymph nodes, resulting in lymphoid tissue hyperplasia and ultimately in the diffuse effacement of lymph node architecture (Lederman & Margolis, 2008), which was observed in the PE group (Figure 7). The decrease in platelets, which is correlated with immunological compromise and virus-related mechanisms, was also detected in the PE group. The significant increase in monocytes and decrease in T cells in peripheral blood indicated changes to the immune system in the PE group. These results showed that NPMs in the PE group were more seriously immunocompromised.

Considering the parasitic detection results in the PE group before and after viral infection, parasites may exit hosts that are seriously immunocompromised. Doenhoff et al. (1986) found that granuloma formation and consequent schistosome egg excretion might be reduced in animal models of immunosuppression. This was supported by subsequent studies in humans (Karanja et al., 1997; Mwanakasale et al., 2003; N’Zoukoudi-N’Doundou et al., 1995). Conversely, another hypothesis suggests that schistosomal infection could be regarded as an immune reconstitution marker following antiretroviral therapy, whereby pathological responses to schistosomes and schistosome eggs are inhibited in advanced HIV disease and deteriorate with immune recovery (De Silva et al., 2006; Fernando & Miller, 2002). Additionally, in contrast to the theory that deworming is a preventive and possible therapeutic measure for patients with co-infection of helminths and HIV (Borkow & Bentwich, 2006; Walson et al., 2009; Walson & John-Stewart, 2007), recent meta-analysis provides stronger evidence that deworming has little or no favorable effect on HIV treatment (Means et al., 2016). These studies suggest that changes in the host induced by HIV or SIV produce adverse effects on parasites, and parasites might not contribute to the progression of HIV disease, matching the hypothesis of Brown et al. (2006).

There were three notable limitations to this study. First, there were only six NPMs enrolled, which might not fully represent the differences between PE and PR groups. Second, feces detection is regarded as the gold standard for the detection of some parasites, particularly intestinal parasites. Unfortunately, we did not collect fecal samples from the six NPMs before viral infection. Therefore, all experiments were performed using antigen or antibody ELISA kits. Finally, tissues were collected from only two NPMs. The other survivors were kept for long-term parasitic experiments. Euthanasia was not performed in this study. However, most of the results in this study showed an identical trend suggesting the conclusions were effective and meaningful.

CONCLUSIONS

To the best of our knowledge, this study is the first to provide direct evidence on the changes in parasitic infection status before and after SIV injection in an animal model. Both HIV and SIV destroy the host immune system, leading to serious immunological compromise, which enhances the possibility for pathogenic microorganisms, including bacteria, fungi, and viruses, to invade and cause damage. In contrast, our results indicated that parasites may exit an immunocompromised host. These prospective results should be evaluated further with a larger sample size.

COMPETING INTERESTS

The authors declare that they have no competing interests.

AUTHORS’ CONTRIBUTIONS

T.Z.S. and Y.T.Z drafted the experiments. T.Z.S., M.X.Z., Y.J.X., Y.X., W.P. performed the experiments. T.Z.S. and M.X.Z. analyzed the data. T.Z.S. and Y.T.Z. wrote the paper. All authors read and approved the final manuscript.

Funding Statement

This work was partly supported by grants from the National Natural Science Foundation of China (81471620; 81671627; 81571606; 81601808; 81172876; U0832601), National Basic Research Program of China (2012CBA01305), 13th Five-Year Key Scientific and Technological Program of China (2017ZX10304402-002-004; 2017ZX10202102-001-005), and National Key Research & Development (R & D) Plan (2016YFC1201000)

REFERENCES

  1. Bentwich Z., Kalinkovich A., Weisman Z., Borkow G., Beyers N., Beyers A.D. Can eradication of helminthic infections change the face of AIDS and tuberculosis? Immunology Today. 1999;20(11):485–487. doi: 10.1016/S0167-5699(99)01499-1. [DOI] [PubMed] [Google Scholar]
  2. Bentwich Z. Good worms or bad worms: do worm infections affect the epidemiological patterns of other diseases? Reply. Parasitology Today. 2000;16(7):312. doi: 10.1016/S0169-4758(00)01693-8. [DOI] [PubMed] [Google Scholar]
  3. Bonnet F., Lewden C., May T., Heripret L., Jougla E., Bevilacqua S., Costagliola D., Salmon D., Chêne G., Morlat P., The Mortalité 2000 Study Group Opportunistic infections as causes of death in HIV-infected patients in the HAART era in France. Scandinavian Journal of Infectious Diseases. 2005;37(6–7):482–487. doi: 10.1080/00365540510035328. [DOI] [PubMed] [Google Scholar]
  4. Borkow G., Bentwich Z. HIV and helminth co-infection: is deworming necessary? Parasite Immunology. 2006;28(11):605–612. doi: 10.1111/j.1365-3024.2006.00918.x. [DOI] [PubMed] [Google Scholar]
  5. Brenchley J.M., Price D.A., Schacker T.W., Asher T.E., Silvestri G., Rao S., Kazzaz Z., Bornstein E., Lambotte O., Altmann D., Blazar B.R., Rodriguez B., Teixeira-Johnson L., Landay A., Martin J.N., Hecht F.M., Picker L.J., Lederman M.M., Deeks S.G., Douek D.C. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nature Medicine. 2006;12(12):1365–1371. doi: 10.1038/nm1511. [DOI] [PubMed] [Google Scholar]
  6. Brown M., Mawa P.A., Kaleebu P., Elliott A.M. Helminths and HIV infection: epidemiological observations on immunological hypotheses. Parasite Immunology. 2006;28(11):613–623. doi: 10.1111/j.1365-3024.2006.00904.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. De Silva S., Walsh J., Brown M. Symptomatic Schistosoma mansoni infection as an immune restoration phenomenon in a patient receiving antiretroviral therapy. Clinical Infectious Diseases. 2006;42(2):303–304. doi: 10.1086/499109. [DOI] [PubMed] [Google Scholar]
  8. Doenhoff M.J., Hassounah O., Murare H., Bain J., Lucas S. The schistosome egg granuloma: Immunopathology in the cause of host protection or parasite survival? Transactions of the Royal Society of Tropical Medicine and Hygiene. 1986;80(4):503–514. doi: 10.1016/0035-9203(86)90126-4. [DOI] [PubMed] [Google Scholar]
  9. Douek D. HIV disease progression: immune activation, microbes, and a leaky gut. Topics in HIV Medicine. 2007;15(4):114–117. [PubMed] [Google Scholar]
  10. Fernando R., Miller R. Immune reconstitution eosinophilia due to schistosomiasis. Sexually Transmitted Infections. 2002;78(1):76. doi: 10.1136/sti.78.1.76. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Griffin G.E. Human immunodeficiency virus and the gastrointestinal tract. Baillière's Clinical Gastroenterology. 1990;4(1):119–134. doi: 10.1016/0950-3528(90)90042-F. [DOI] [PubMed] [Google Scholar]
  12. Ipp H., Zemlin A.E., Erasmus R.T., Glashoff R.H. Role of inflammation in HIV-1 disease progression and prognosis. Critical Reviews in Clinical Laboratory Sciences. 2014;51(2):98–111. doi: 10.3109/10408363.2013.865702. [DOI] [PubMed] [Google Scholar]
  13. Jeang K.T., August J.T., Murad F. 2nd ed. Academic Press; New York: 2007. HIV-1: Molecular Biology and Pathogenesis: Viral Mechanisms. [Google Scholar]
  14. Karanja D.M., Colley D.G., Nahlen B.L., Ouma J.H., Secor W.E. Studies on schistosomiasis in western Kenya: I. Evidence for immune-facilitated excretion of schistosome eggs from patients with Schistosoma mansoni and human immunodeficiency virus coinfections. The American Journal of Tropical Medicine and Hygiene. 1997;56(5):515–521. doi: 10.4269/ajtmh.1997.56.515. [DOI] [PubMed] [Google Scholar]
  15. Karlsson G.B., Halloran M., Li J., Park I.W., Gomila R., Reimann K.A., Axthelm M.K., Iliff S.A., Letvin N.L., Sodroski J. Characterization of molecularly cloned simian-human immunodeficiency viruses causing rapid CD4+ lymphocyte depletion in rhesus monkeys. Journal of Virology. 1997;71(6):4218–4225. doi: 10.1128/jvi.71.6.4218-4225.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Lederman M.M., Margolis L. The lymph node in HIV pathogenesis. Seminars in Immunology. 2008;20(3):187–195. doi: 10.1016/j.smim.2008.06.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Letvin N.L. Animal models for the study of human immunodeficiency virus infections. Current Opinion in Immunology. 1992;4(4):481–485. doi: 10.1016/S0952-7915(06)80043-9. [DOI] [PubMed] [Google Scholar]
  18. Means A.R., Burns P., Sinclair D., Walson J.L. Antihelminthics in helminth-endemic areas: effects on HIV disease progression. The Cochrane Database of Systematic Reviews. 2016;(4):Cd006419. doi: 10.1002/14651858.CD006419.pub4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Mestecky J., Moldoveanu Z., Smith P.D., Hel Z., Alexander R.C. Mucosal immunology of the genital and gastrointestinal tracts and HIV-1 infection. Journal of Reproductive Immunology. 2009;83(1–2):196–200. doi: 10.1016/j.jri.2009.07.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Murphy K., Weaver C. 9th ed. Garland Science; New York and London: 2016. Janeway’s immunobiology. [Google Scholar]
  21. Mwanakasale V., Vounatsou P., Sukwa T.Y., Ziba M., Ernest A., Tanner M. Interactions between Schistosoma haematobium and human immunodeficiency virus type 1: The effects of coinfection on treatment outcomes in rural Zambia. The American Journal of Tropical Medicine and Hygiene. 2003;69(4):420–428. [PubMed] [Google Scholar]
  22. N’Zoukoudi-N’Doundou M.Y., Dirat I., Akouala J.J., Penchenier L., Makuwa M., Rey J.L. Bilharziasis and human immunodeficiency virus infection in Congo. Médecine Tropicale: Revue du Corps de Santé Colonial. 1995;55(3):249–251. (in French) [PubMed] [Google Scholar]
  23. O’Bryan T.A., Okulicz J.F., Bradley W.P., Ganesan A., Wang X., Agan B.K. Impact of the highly active antiretroviral therapy era on the epidemiology of primary HIV-associated thrombocytopenia. BMC Research Notes. 2015;8:595. doi: 10.1186/s13104-015-1548-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Palladino C., Climent F.J., De José M.I., Jimenez De Ory S., Bellón J.M., Guillén S., Gurbindo M.D., González-Tomé I., Mellado M.J., Martínez Pérez J., Calvo C., Ramos J.T., Muñoz-Fernández M.Á. Causes of death in pediatric patients vertically infected by the human immunodeficiency virus type 1 in Madrid, Spain, from 1982 to mid-2009. Pediatric Infectious Disease Journal. 2011;30(6):495–500. doi: 10.1097/INF.0b013e318211399f. [DOI] [PubMed] [Google Scholar]
  25. Pang W., Zhang G.H., Jiang J., Zheng H.Y., Zhang L.T., Zhang X.L., Song J.H., Zhang M.X., Zhu J.W., Lei A.H., Tian R.R., Liu X.M., Zhang L.G., Gao G.X., Su L.S., Zheng Y.T. HIV-1 can infect northern pig-tailed macaques (Macaca leonina) and form viral reservoirs in vivo. Science Bulletin. 2017;62(19):1315–1324. doi: 10.1016/j.scib.2017.09.020. [DOI] [PubMed] [Google Scholar]
  26. Pantaleo G., Graziosi C., Demarest J.F., Butini L., Montroni M., Fox C.H., Orenstein J.M., Kotler D.P., Fauci A.S. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature. 1993a;362(6418):355–358. doi: 10.1038/362355a0. [DOI] [PubMed] [Google Scholar]
  27. Pantaleo G., Graziosi C., Fauci A.S. The role of lymphoid organs in the pathogenesis of HIV infection. Seminars in Immunology. 1993b;5(3):157–163. doi: 10.1006/smim.1993.1019. [DOI] [PubMed] [Google Scholar]
  28. Rajasuriar R., Khoury G., Kamarulzaman A., French M.A., Cameron P.U., Lewin S.R. Persistent immune activation in chronic HIV infection: do any interventions work? AIDS. 2013;27(8):1199–1208. doi: 10.1097/QAD.0b013e32835ecb8b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Rowley C.F. Developments in CD4 and viral load monitoring in resource-limited settings. Clinical Infectious Diseases. 2014;58(3):407–412. doi: 10.1093/cid/cit733. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. The Antiretroviral Therapy Cohort Collaboration Causes of death in HIV-1—infected patients treated with antiretroviral therapy, 1996–2006: Collaborative analysis of 13 HIV cohort studies. Clinical Infectious Diseases. 2010;50(10):1387–1396. doi: 10.1086/652283. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Tian R.R., Zhang M.X., Zhang L.T., Zhang X.L., Zheng H.Y., Zhu L., Pang W., Zhang G.H., Zheng Y.T. High immune activation and abnormal expression of cytokines contribute to death of SHIV89.6-infected Chinese rhesus macaques. Archives of Virology. 2015;160(8):1953–1966. doi: 10.1007/s00705-015-2455-6. [DOI] [PubMed] [Google Scholar]
  32. Walson J.L., John-Stewart G. Treatment of helminth co-infection in individuals with HIV-1: A systematic review of the literature. PLoS Neglected Tropical Diseases. 2007;1(3):e102. doi: 10.1371/journal.pntd.0000102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Walson J.L., Herrin B.R., John-Stewart G. Deworming helminth co-infected individuals for delaying HIV disease progression. The Cochrane Database of Systematic Reviews. 2009;(3):Cd006419. doi: 10.1002/14651858.CD006419.pub3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Warhurst D.C., Warhurst J.E. ACP Broadsheet no 148. July 1996. Laboratory diagnosis of malaria. Journal of Clinical Pathology. 1996;49(7):533–538. doi: 10.1136/jcp.49.7.533. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Xia H.J., Zhang G.H., Wang R.R., Zheng Y.T. The influence of age and sex on the cell counts of peripheral blood leukocyte subpopulations in Chinese rhesus macaques. Cellular & Molecular Immunology. 2009;6(6):433–440. doi: 10.1038/cmi.2009.55. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Zhang M.X., Zheng H.Y., Jiang J., Song J.H., Chen M., Xiao Y., Lian X.D., Song T.Z., Tian R.R., Pang W., Zheng Y.T. Northern Pig-tailed Macaques (Macaca leonina) maintain superior CD4+ T cell homeostasis during SIVmac239 infection. European Journal of Immunology. 2017a doi: 10.1002/eji.201747284. (in Press) [DOI] [PubMed] [Google Scholar]
  37. Zhang M.X., Zheng H.Y., Jiang J., Song J.H., Chen M., Xiao Y., Lian X.D., Song T.Z., Tian R.R., Pang W., Zheng Y.T. Predict disease progression from T-cell phenotypes in northern pig-tailed macaques (Macaca leonina) during SIVmac239 infection. Immunology. 2017b;152(4):574–579. doi: 10.1111/imm.12794. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Zheng H.Y., Zhang M.X., Pang W., Zheng Y.T. Aged Chinese rhesus macaques suffer severe phenotypic T- and B-cell aging accompanied with sex differences. Experimental Gerontology. 2014;55:113–119. doi: 10.1016/j.exger.2014.04.004. [DOI] [PubMed] [Google Scholar]

Articles from Zoological Research are provided here courtesy of Editorial Office of Zoological Research, Kunming Institute of Zoology, The Chinese Academy of Sciences

RESOURCES